197 filings
Page 7 of 10
6-K
5q4jq5kj
30 Mar 17
Affimed Reports Financial Results for Fourth Quarter
12:00am
6-K/A
s079hnjbf8rdru
9 Feb 17
Current report (foreign) (amended)
12:00am
6-K
gutory
8 Feb 17
Current report (foreign)
12:00am
6-K
jhjploj ce5uc9k4sn
25 Jan 17
Current report (foreign)
12:00am
424B5
oscacg2grke5
24 Jan 17
Prospectus supplement for primary offering
12:00am
424B5
qfa9rx6
19 Jan 17
Prospectus supplement for primary offering
12:00am
6-K
n3qcchf8
11 Jan 17
Affimed Provides Update on NK-Cell Immuno-Oncology Platform
12:00am
6-K
v7lski cwpdc0q2cbn1
5 Jan 17
Transforming Immuno - Oncology Using Next - Generation Immune Cell Engagers Corporate Presentation January 2017
12:00am
6-K
wvrlgu18t
4 Jan 17
Agreement Brings Together MD Anderson’s Natural Killer Cell and Affimed’s Antibody-based Technologies
12:00am
424B5
8205 4hn1m
15 Dec 16
Prospectus supplement for primary offering
12:00am
6-K
98v9ze
6 Dec 16
Current report (foreign)
12:00am
6-K
cbmh 6gqr
2 Nov 16
Index to Condensed Consolidated Financial Statements
12:00am
6-K
rb3y9venwmd9fpggxjm
10 Aug 16
Index to Condensed Consolidated Financial Statements
12:00am
6-K
pru4e2qir hx2eip1vl
1 Jul 16
Current report (foreign)
12:00am
6-K
3umi hkexgra
22 Jun 16
Current report (foreign)
12:00am
6-K
nns ufbqlj0ztei8r2
23 May 16
Affimed Announces Annual General Meeting of Shareholders
12:00am
6-K
wfvvx 299
18 May 16
Index to Condensed Consolidated Financial Statements
12:00am
6-K
66vlxwtn
30 Mar 16
Affimed Reports Financial Results for Fourth Quarter
12:00am